Expression and Function of the Developmental Gene Wnt-4 During Experimental Acute Renal Failure in Rats
Overview
Authors
Affiliations
The Wnt-beta-catenin pathway plays key roles in embryogenesis. Wnt-4 is known to be expressed in the mesonephric duct in embryonic development. It is tempting to speculate that the Wnt-4-beta-catenin pathway contributes to the recovery from acute renal failure (ARF). This study used an in vivo model of ARF rats to clarify the significance of the Wnt-4-beta-catenin pathway in ARF. ARF was induced by clamping the rat left renal artery for 1 h. At 3, 6, 12, 24, 48, and 72 h after reperfusion, whole kidney homogenate and total RNA were extracted for examination by Western blot analysis and real-time RT-PCR. Wnt-4 mRNA and protein expression were strongly increased at 3 to 12 h and 6 to 24 h after ischemia, respectively. In immunohistologic examination, Wnt-4 was expressed in the proximal tubules and co-expressed with aquaporin-1, GM130, and PCNA. Cyclin D1 and cyclin A were expressed at 24 to 48 h after reperfusion. In addition, the overexpression of Wnt-4 and beta-catenin promoted the cell cycle and increased the promoter activity and protein expression of cyclin D1 in LLC-PK1 cells. Taken together, these data suggest that the Wnt-4-beta-catenin pathway plays a key role in the cell cycle progression of renal tubules in ARF. The Wnt-4-beta-catenin pathway may regulate the transcription of cyclin D1 and control the regeneration of renal tubules in ARF.
The crosstalk of Wnt/β-catenin signaling and p53 in acute kidney injury and chronic kidney disease.
Ming W, Wen L, Hu W, Qiao R, Zhou Y, Su B Kidney Res Clin Pract. 2024; 43(6):724-738.
PMID: 39558651 PMC: 11615452. DOI: 10.23876/j.krcp.23.344.
Ogamino S, Yamamichi M, Sato K, Ishitani T NPJ Aging. 2024; 10(1):23.
PMID: 38684674 PMC: 11059364. DOI: 10.1038/s41514-024-00149-1.
Kidney Injury: Focus on Molecular Signaling Pathways.
Liu W, Hu M, Wang L, Mirzaei H Curr Med Chem. 2024; 31(28):4510-4533.
PMID: 38314680 DOI: 10.2174/0109298673271547231108060805.
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.
Zhang M, Liu Q, Meng H, Duan H, Liu X, Wu J Signal Transduct Target Ther. 2024; 9(1):12.
PMID: 38185705 PMC: 10772178. DOI: 10.1038/s41392-023-01688-x.
Kim C, Kwak W, Won D, Kim J, Hwang D, Kim N Cell Biol Toxicol. 2023; 39(6):3197-3217.
PMID: 37603122 DOI: 10.1007/s10565-023-09827-4.